https://www.selleckchem.com/products/brd7389.html
fforts of clinical trials to investigate the potential role of immunotherapy in anal cancer. This is the first detailed report demonstrating that standard chemoradiation (CRT) commonly results in treatment-related lymphopenia (TRL), which may be associated with a poorer overall survival (OS) in patients with anal squamous cell carcinoma. The association between TRL and worse OS observed in this study supports the importance of host immunity in survival among patients with anal cancer. These findings encourage larger, prospective studies
Like
Comment
Share
